JENNIFER WEST: Open Payments
NPI 1629520655 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,962 in 53 payments from 24 companies in 2025. Trend: 2023 $29,638 · 2024 $13,636 · 2025 $2,962
Speaker / faculty: $1,502Food & beverage: $1,433Travel & lodging: $27
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $1,755 |
| Daiichi Sankyo Inc. | 6 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Janssen Biotech, Inc. | 5 | $119 |
| Gilead Sciences, Inc. | 4 | $94 |
| SOBI, INC | 3 | $71 |
| Lilly USA, LLC | 2 | $58 |
| Janssen Scientific Affairs, LLC | 2 | $52 |
| Celgene Corporation | 2 | $50 |
| Pharmacosmos Therapeutics Inc. | 2 | $49 |
Products named: Enhertu, HYQVIA, DARZALEX, Trodelvy, Doptelet, VERZENIO, REBLOZYL, LIBTAYO.
Industry payments across TX — which companies pay providers there.
